Augere Medical (Augere), a European pioneer in AI-assisted colonoscopy, announced the commercial release of its next-generation software module 1.9 for real-time polyp detection on colonoscopy systems.
The release increases transparency of AI behaviour using the unique real-time Confidence Indicator, giving endoscopists more control over how AI-support is presented during procedures.
The software introduces an advanced false-positive reduction filter that increases the framewise sensitivity by more than 20 per cent compared to previous generations, while preserving the same high sensitivity for clinically relevant lesions. Using the new filtering method, Augere has been able to preserve the low false positive rate that users have come to appreciate from the PolypAID system. This helps endoscopists stay focused on true findings, with fewer distractions on the screen and less time spent investigating non-lesions.
“Endoscopists tell us they want the benefits of a highly sensitive AI for adenoma detection, but not at the price of constant, unnecessary alerts,” says Jon H. Hoem, CEO at Augere. “This release is designed to make AI support feel calmer and more usable during back-to-back procedures, especially in busy European screening units.”
The software has been developed with a particular focus on European hospitals and endoscopy units where ESGE-style quality indicators and scrutiny of AI-related harms (false positives, distractions, additional time) are central to adoption decisions. By combining false-positive control, rapid confidence stabilization, and practical integration with existing endoscopy infrastructures, the release is positioned as an enabling step towards broader, routine use of AI in colonoscopy.
“Transparency is no longer optional for clinical AI,” commented Pia H. Smedsrud, Chief Medical Officer at Augere. “Showing confidence intuitively gives physicians an immediate sense of how much weight to put on each alert, while keeping the final decision strictly with the endoscopists. Although the final decision is always the endoscopists’ responsibility, the indicator provides an intuitive way and immediate sense of how much weight to put on each alert.”
The new software version will be available for installations in selected European markets starting in Q1 2026, with a phased rollout to additional centres thereafter. Existing customers will be offered upgrade pathways that preserve their current hardware investments.
